Skip to main content

Want a detailed portfolio tracker?

Veru (VERU) P/E (2010 - 2026)

Veru (VERU) P/E from Jun 30, 2010 to Jun 12, 2026. The TTM Veru (VERU) P/E is -3.32. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Veru (VERU)

YearP/EChange
2026-3.32+97.28%
2025-1.68-32.03%
2024-2.47+349.10%
2023-0.55-93.87%
2022-8.99-69.06%
2021-29.04-104.90%
2020593.04-3726.65%
2019-16.35+204.31%
2018-5.37-49.43%
2017-10.63-233.50%
20167.96-1.38%
20158.07-72.56%
201429.42+12.31%
201326.19+39.68%
201218.75-92.31%
2011243.75-86.64%
20101.82KN/A

Comparison Veru (VERU) P/E with competitors

Veru (VERU) P/E is -3.32.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.05%
NBYStablecoin Development Corp0.00-100.13%
ENLVEnlivex Therapeutics Ltd0.13-103.89%
FGENFibroGen Inc0.24-107.23%
TRAWTraws Pharma Inc0.47-114.25%
FBIOFortress Biotech Inc0.71-121.35%
CHRSCoherus Biosciences Inc0.80-124.15%
ORMPOramed Pharmaceuticals Inc1.37-141.28%
AGENAgenus Inc1.84-155.58%
VIVSVivoSim Labs Inc2.32-169.90%
INVAInnoviva Inc3.31-199.87%
CRMDCorMedix Inc3.78-213.90%
VXRTVaxart Inc3.95-219.09%
ABEOAbeona Therapeutics Inc3.96-219.38%
SRPTSarepta Therapeutics Inc4.19-226.24%
CVACCureVac N.V.4.45-233.98%
GLPGGalapagos NV4.86-246.43%
ABUSArbutus Biopharma Corp5.06-252.36%
RIGLRigel Pharmaceuticals5.16-255.45%
CGENCompugen Ltd5.24-258.03%
ZVRAZevra Therapeutics Inc6.13-284.81%
OMEROmeros Corporation9.11-374.46%
PLXProtalix BioTherapeutics Inc9.21-377.51%
SPROSpero Therapeutics Inc9.31-380.46%
AUPHAurinia Pharmaceuticals Inc9.32-380.97%
ACADAcadia Pharmaceuticals Inc9.62-389.78%
TBPHTheravance Biopharma Inc11.86-457.32%
ADMAAdma Biologics Inc12.13-465.63%
SABSSAB Biotherapeutics Inc12.93-489.54%
HRMYHarmony Biosciences Holdings Inc14.05-523.42%
REGNRegeneron Pharmaceuticals Inc14.36-532.71%
PBYIPuma Biotechnology Inc14.45-535.59%
INCYIncyte Corp14.49-536.66%
NAGENiagen Bioscience Inc14.82-546.58%
XOMAXOMA Corp14.95-550.64%
TGTXTG Therapeutics Inc15.67-572.38%
EXELExelixis Inc16.60-600.29%
CPRXCatalyst Pharmaceuticals Inc17.36-623.07%
MDXGMimedx Group Inc17.52-628.01%
CTMXCytomX Therapeutics Inc19.63-691.54%
ASNDAscendis Pharma A/S23.50-808.27%
HALOHalozyme Therapeutics Inc23.83-818.06%
ARGXArgen X SE24.24-830.54%
XOMAOXOMA Corp25.34-863.84%
VRTXVertex Pharmaceuticals Inc25.57-870.54%
XOMAPXOMA Corp25.67-873.65%
RPRXRoyalty Pharma plc - Class A27.78-937.10%
SLNOSoleno Therapeutics Inc29.02-974.46%
LGNDLigand Pharmaceuticals Inc - Class B31.77-1057.39%
APLSApellis Pharmaceuticals Inc39.02-1276.02%
BMRNBiomarin Pharmaceutical Inc40.22-1312.18%
KRYSKrystal Biotech Inc40.45-1318.96%
ONCBeiGene Ltd58.89-1874.97%
PHARPharming Group N.V.68.77-2172.73%
TECHBio-Techne Corp74.88-2356.90%
VCELVericel Corp87.95-2750.53%
GMABGenmab118.15-3660.72%
ALNYAlnylam Pharmaceuticals Inc123.07-3809.09%
TLXTelix Pharmaceuticals Ltd135.58-4186.18%
CORTCorcept Therapeutics Inc185.65-5695.04%